Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
fisiospray
- Development stage
- Unknown
- Lead developer
- Fisiocrem International
- Administration
- Topical
01
Overview
**fisiospray** is an Australian topical herbal analgesic spray developed and marketed by Fisiocrem International for temporary relief of muscular aches and pains, sprains, strains, mild joint pain and stiffness, mild nerve pain, and symptoms of soft-tissue trauma. It is supplied as a 100 mL topical spray containing *Urtica dioica* leaf liquid extract, spearmint oil, rosemary oil, and eucalyptus oil. The product is intended to provide localized, cooling symptomatic pain relief and support comfort and mobility; no specific molecular target or receptor-mediated mechanism is stated by the sponsor.
- Brand names
- fisiospray
Beyond the preview
Go deeper on fisiospray.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on fisiospray.